Article Details

Bicycle Therapeutics (NASDAQ:BCYC) Rating Increased to Hold at Zacks Investment Research

Retrieved on: 2019-12-04 20:22:02

Tags for this article:

Click the tags to see associated articles and topics

Bicycle Therapeutics (NASDAQ:BCYC) Rating Increased to Hold at Zacks Investment Research. View article details on hiswai:

Excerpt

<div>Finally, <b>Atlas Venture</b> Advisors Inc. purchased a new position in shares of Bicycle Therapeutics in the 2nd quarter worth approximately $13,709,000.</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo